Related Experiment Videos
Delayed cutaneous hypersensitivity and lymphocyte transformation: dissociation in atopic dermatitis
Archives of Dermatology
|January 1, 1979
Summary
Atopic dermatitis patients often show skin anergy despite normal lymphocyte responses, indicating a disconnect in cell-mediated immunity. This immune dysfunction in atopic dermatitis requires further investigation.
Area of Science:
- Immunology
- Dermatology
- Cellular Immunity
Background:
- Cell-mediated immunity (CMI) studies in atopic dermatitis yield inconsistent findings, leaving immune dysfunction unclear.
- Existing research presents varied defects and contradictory results regarding CMI in atopic dermatitis.
Purpose of the Study:
- To investigate immune dysfunction in atopic dermatitis by assessing both delayed cutaneous hypersensitivity and in vitro lymphocyte transformation.
- To clarify the nature of immune system defects in atopic dermatitis by examining CMI responses.
Main Methods:
- Assessed delayed cutaneous hypersensitivity and in vitro lymphocyte transformation responses.
- Utilized Candida albicans and streptokinase-streptodornase (SKSD) as test antigens.
- Compared responses between atopic dermatitis patients and healthy controls.
Main Results:
- Atopic patients predominantly exhibited cutaneous anergy (96% to candidin, 84% to SKSD).
- Mean in vitro lymphocyte transformation was comparable between atopic patients and controls, with some exceptions in severe cases.
- A significant lack of correlation was observed between in vitro and cutaneous immune responses in atopic patients.
Conclusions:
- Atopic dermatitis is characterized by a dissociation between in vitro lymphocyte responses and in vivo cutaneous hypersensitivity.
- Cutaneous anergy in the presence of normal lymphocyte transformation suggests a specific immune defect in atopic dermatitis.
- Further research is needed to fully elucidate the complex immune dysregulation in atopic dermatitis.